ClinicalTrials.gg
CompletedNCT04758728ARESQOLSAVESUpdated Feb 18, 2021

Adrenaline Reduces Ecchymoses and Hematomas and Improves Quality of Life After Classic Saphenous Vein Stripping

An interventional study of Great saphenous vein stripping and varicectomies and Epinephrine Topical in Venous Insufficiency (Chronic)(Peripheral), Venous Reflux and Venous Insufficiency of Leg, sponsored by Junior Doctors Network-Hellas. Completed at 1 site in Greece. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2021-02-18.

Sponsored by Junior Doctors Network-Hellas · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 5 years 4 months after the study started (first participant enrolled Sep 2015, registered Feb 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Aim of the present study is to investigate the efficiency of adrenaline (epinephrine) used locally in reducing and avoiding post-operative formation of subcutaneous ecchymoses and hematomas, in comparison with traditional practice of hemostasis, and to assess improvement in the quality of life of subjects undergoing classic great saphenous vein stripping, who received or did not receive adrenaline as a local hemostatic.

Read the detailed description

Introduction Quality of life of subjects undergoing classic great saphenous vein stripping is analogous of the gravity of subcutaneous ecchymoses and hematomas formation, as a result of surgical interventions during open surgery, when the great saphenous vein is being removed. Adrenaline (epinephrine) is a potent vasoconstrictor, whose local hemostatic ability has already been documented and applied in many medical specialties. Aim of the present study to investigate the efficiency of adrenaline (epinephrine) used locally in reducing and avoiding post-operative formation of subcutaneous ecchymoses and hematomas, in comparison with traditional practice of hemostasis, and to assess improvement in the quality of life of subjects undergoing classic great saphenous vein stripping, who received or did not receive adrenaline as a local hemostatic.

Material-Methods 40 subjects diagnosed with chronic venous insufficiency (CVI) and/or varicose veins of the lower limbs of varied clinical gravity (CEAP classification II \& III), admitted in the department of Vascular Surgery for open surgical management, i.e. great saphenous vein stripping +/- removal of varicosities, will be enrolled after signing an informed consent for their participation in the study. They will be then randomized into 3 separate groups: Group A - great saphenous vein stripping with local adrenaline use for hemostasis Group B - great saphenous vein stripping with local normal saline use for hemostasis Group C - great saphenous vein stripping with traditional hemostatic practice Study subjects will be followed-up after surgery, and in each group measurement of ecchymoses (small 2-5mm2 and large >5mm2) and hematomas (medium 0,2-1cm and large >1cm) will be performed by using ImageJ software after digital high-resolution photographing on 1st, 8th and 14th post-operative days. Quality of life of subjects will be assessed pre-operatively and 1 month post-operatively, by using SF-36 and CIVIQ-2 questionnaires for QoL in CVI.

02

Conditions studied

  • Venous Insufficiency (Chronic)(Peripheral)
  • Venous Reflux
  • Venous Insufficiency of Leg
  • Venous Stasis
  • Venous Disease
  • Subcutaneous Haematoma
  • Ecchymosis
  • Bruising

Keywords

  • great saphenous vein
  • saphenectomy
  • saphenous vein stripping
  • ecchymosis
  • haematoma
  • adrenaline
  • epinephrin
  • hemostasis
  • chronic venous insufficiency
  • venous reflux
  • venous disease
03

In context

Venous Insufficiency

162 studies on the registry are indexed under Venous Insufficiency; 14 are open to participants now.

This study's enrollment of 40 is below the median of 60 across 127 interventional studies indexed under Venous Insufficiency.

Browse Venous Insufficiency studies →

Lead sponsor

This is the only study on the registry with Junior Doctors Network-Hellas as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18-80 years
  • CVI CEAP Class II or III
  • signed

Exclusion criteria

Exclusion Criteria:

  • Age \<18 or >80 years
  • CVI CEAP Class I or IV (venous ulcers)
  • Allergy to adrenaline history
  • No signed
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
40 participants (actual)

Study arms

  • Active comparator
    Group A

    Group A - great saphenous vein stripping with local adrenaline use for hemostasis

    Procedure: Great saphenous vein stripping and varicectomies · Drug: Epinephrine Topical

  • Sham comparator
    Group B

    Group B - great saphenous vein stripping with local normal saline use for hemostasis

    Procedure: Great saphenous vein stripping and varicectomies · Drug: normal saline

  • Sham comparator
    Group C

    Group C - great saphenous vein stripping with traditional hemostatic practice

    Procedure: Great saphenous vein stripping and varicectomies

Interventions

  • ProcedureGreat saphenous vein stripping and varicectomies

    Removal of the great saphenous vein (partially - from just below the knee up to the saphenofemoral junction) by two 3cm skin and subcutaneous fat incisions and the introduction of a conventional vein stripper device, under general or epidural/regional anesthesia. Removal of varicose veins of the lower limb by 0,5cm skin incisions and the use of a conventional phlebectomy stainless steel hook. Mechanical hemostasis by direct compression of the thigh for 10 minutes.

    Also known as: Saphenectomy

  • DrugEpinephrine Topical

    Use of epinephrine/adrenaline solution 1:1000 topically

    Also known as: Adrenaline solution 1:1000 topical/local use

  • Drugnormal saline

    Use of normal saline solution NaCl 0,9% topically

    Also known as: NaCl 0,9% topical/local use

06

What researchers measure

Primary outcomes

  1. Subcutaneous ecchymoses number 1d-postop

    The absolute number of subcutaneous ecchymoses on the operated limb on 1st post-operative day

    Time frame: 24 hours post-operatively

  2. Subcutaneous ecchymoses number 8d-post-op

    The absolute number of subcutaneous ecchymoses on the operated limb on 8th post-operative day

    Time frame: 192 hours post-operatively

  3. Subcutaneous ecchymoses number 14d-post-op

    The absolute number of subcutaneous ecchymoses on the operated limb on 14th post-operative day

    Time frame: 336 hours post-operatively

  4. Subcutaneous hematomas number 1d-postop

    The absolute number of subcutaneous hematomas in the operated limb on 1st post-operative day

    Time frame: 24 hours post-operatively

  5. Subcutaneous hematomas number 8d-postop

    The absolute number of subcutaneous hematomas in the operated limb on 8th post-operative day

    Time frame: 192 hours post-operatively

  6. Subcutaneous hematomas number 14d-postop

    The absolute number of subcutaneous hematomas in the operated limb on 14th post-operative day

    Time frame: 336 hours post-operatively

  7. Subcutaneous ecchymoses total area 1d-postop

    The total area in mm2 of subcutaneous ecchymoses in the operated limb on 1st post-operative day

    Time frame: 24 hours post-operatively

  8. Subcutaneous ecchymoses total area 8d-postop

    The total area in mm2 of subcutaneous ecchymoses in the operated limb on 8th post-operative day

    Time frame: 192 hours post-operatively

  9. Subcutaneous ecchymoses total area 14d-postop

    The total area in mm2 of subcutaneous ecchymoses in the operated limb on 14th post-operative day

    Time frame: 336 hours post-operatively

  10. Subcutaneous hematomas total area 1d-postop

    The total area in mm2 of subcutaneous hematomas in the operated limb on 1st post-operative day

    Time frame: 24 hours post-operatively

  11. Subcutaneous hematomas total area 8d-postop

    The total area in mm2 of subcutaneous hematomas in the operated limb on 8th post-operative day

    Time frame: 192 hours post-operatively

  12. Subcutaneous hematomas total area 14d-postop

    The total area in mm2 of subcutaneous hematomas in the operated limb on 14th post-operative day

    Time frame: 336 hours post-operatively

  13. QoL-SF36 preop

    Quality of life assessment based on the 36-Item Short Form Survey (SF-36) questionnaire preoperatively. It is an often-used, well-researched, self-reported measure of health. It stems from a study called the Medical Outcomes Study. It taps eight health concepts: physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perceptions. It also includes a single item that provides an indication of perceived change in health. The eight scaled scores, which are the weighted sums of the questions in their section are directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.

    Time frame: 24 hours pre-operatively

  14. QoL-SF36 1month-postop

    Quality of life assessment based on the 36-Item Short Form Survey (SF-36) questionnaire 30 days post-operatively. It is an often-used, well-researched, self-reported measure of health. It stems from a study called the Medical Outcomes Study. It taps eight health concepts: physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perceptions. It also includes a single item that provides an indication of perceived change in health. The eight scaled scores, which are the weighted sums of the questions in their section are directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.

    Time frame: 30 days post-operatively

  15. QoL-CIVIQ2 preop

    Quality of life assessment based on the ChronIc Venous Insufficiency quality of life Questionnaire version 2 (CIVIQ-2) questionnaire preoperatively. The CIVIQ was developed and validated (relevance, acceptability, reliability, construct validity, and sensitivity) by French researchers in 1996. The CIVIQ is a 20-item self-reported instrument that includes four categories of questions: physical (4 items), psychological (9 items), social (4 items), and pain (3 items). Its score ranges from 0, the worst score, to 100, the best. There are five possible answers (from 1 to 5) to describe each symptom and the sensation of discomfort. The second version, the CIVIQ-2 (where 2 denotes the second draft of the same questionnaire), provides a global score covering all aspects of the questionnaire and weighs the categories equally.

    Time frame: 24 hours pre-operatively

  16. QoL-CIVIQ2 1month post-op

    Quality of life assessment based on the CIVIQ-2 questionnaire 1 month post-operatively. Quality of life assessment based on the ChronIc Venous Insufficiency quality of life Questionnaire version 2 (CIVIQ-2) questionnaire preoperatively. The CIVIQ was developed and validated (relevance, acceptability, reliability, construct validity, and sensitivity) by French researchers in 1996. The CIVIQ is a 20-item self-reported instrument that includes four categories of questions: physical (4 items), psychological (9 items), social (4 items), and pain (3 items). Its score ranges from 0, the worst score, to 100, the best. There are five possible answers (from 1 to 5) to describe each symptom and the sensation of discomfort. The second version, the CIVIQ-2 (where 2 denotes the second draft of the same questionnaire), provides a global score covering all aspects of the questionnaire and weighs the categories equally.

    Time frame: 30 days post-operatively

Secondary outcomes

  1. HCT preop

    Hematocrit (HCT) measured pre-operatively, in percentage (%).

    Time frame: 24 hours pre-operatively

  2. HCT postop

    Hematocrit (HCT) measured post-operatively, in percentage (%).

    Time frame: 24 hours post-operatively

  3. Hgb preop

    Hemoglobin (Hgb) measured pre-operatively, in mg/dL.

    Time frame: 24 hours pre-operatively

  4. Hgb postop

    Hemoglobin (Hgb) measured post-operatively, in mg/dL.

    Time frame: 24 hours post-operatively

  5. WBC preop

    White blood cells (WBC) count measured pre-operatively, in K/mcL.

    Time frame: 24 hours pre-operatively

  6. WBC postop

    White blood cells (WBC) count measured post-operatively, in K/mcL.

    Time frame: 24 hours post-operatively

  7. PLT preop

    Platelet count (PLT) measured pre-operatively, in K/mcL.

    Time frame: 24 hours pre-operatively

  8. PLT postop

    Platelet count (PLT) measured post-operatively, in K/mcL.

    Time frame: 24 hours post-operatively

  9. FIB preop

    Fibrinogen (FIB) measured pre-operatively, in mg/dL.

    Time frame: 24 hours pre-operatively

  10. FIB postop

    Fibrinogen (FIB) measured post-operatively, in mg/dL.

    Time frame: 24 hours post-operatively

  11. ESR preop

    Erythrocyte sedimentation rate on the 1st hour, measured pre-operatively, in millimeters (mm).

    Time frame: 24 hours pre-operatively

  12. ESR postop

    Erythrocyte sedimentation rate on the 1st hour, measured post-operatively, in millimeters (mm).

    Time frame: 24 hours post-operatively

  13. CRP preop

    Serum C-reactive protein (CRP) measured pre-operatively, in mg/L.

    Time frame: 24 hours pre-operatively

  14. CRP postop

    Serum C-reactive protein (CRP) measured post-operatively, in mg/L.

    Time frame: 24 hours post-operatively

  15. Experienced pain preop

    Pain experienced pre-operatively assessed by a numeric rating pain scale (0-10). Numeric Rating Scale (NRS-11) is an 11-point scale for patient self-reporting of pain. It is for adults and children 10 years old or older. 0 indicates no pain, 5 moderate and 10 worst possible pain.

    Time frame: 24 hours pre-operatively

  16. Experienced pain 1d-postop

    Pain experienced pre-operatively assessed by a numeric rating pain scale (0-10). Numeric Rating Scale (NRS-11) is an 11-point scale for patient self-reporting of pain. It is for adults and children 10 years old or older. 0 indicates no pain, 5 moderate and 10 worst possible pain.

    Time frame: 24 hours post-operatively

  17. Experienced pain 8d-postop

    Pain experienced pre-operatively assessed by a numeric rating pain scale (0-10). Numeric Rating Scale (NRS-11) is an 11-point scale for patient self-reporting of pain. It is for adults and children 10 years old or older. 0 indicates no pain, 5 moderate and 10 worst possible pain.

    Time frame: 192 hours post-operatively

  18. Experienced pain 14d-postop

    Pain experienced pre-operatively assessed by a numeric rating pain scale (0-10). Numeric Rating Scale (NRS-11) is an 11-point scale for patient self-reporting of pain. It is for adults and children 10 years old or older. 0 indicates no pain, 5 moderate and 10 worst possible pain.

    Time frame: 336 hours post-operatively

07

Study locations

1 site
  • Department of Vascular Surgery, Andreas Papandreou General Hospital
    Rhodes, South Aegean 85133, Greece
08

References and documents

Publications

  • Furuya T, Tada Y, Sato O. A new technique for reducing subcutaneous hemorrhage after stripping of the great saphenous vein. J Vasc Surg. 1992 Sep;16(3):493-4. doi: 10.1016/0741-5214(92)90389-p. No abstract available. PubMed 1522653 ↗
  • Nisar A, Shabbir J, Tubassam MA, Shah AR, Khawaja N, Kavanagh EG, Grace PA, Burke PE. Local anaesthetic flush reduces postoperative pain and haematoma formation after great saphenous vein stripping--a randomised controlled trial. Eur J Vasc Endovasc Surg. 2006 Mar;31(3):325-31. doi: 10.1016/j.ejvs.2005.08.006. Epub 2005 Oct 19. PubMed 16236532 ↗
  • Pappa E, Kontodimopoulos N, Niakas D. Validating and norming of the Greek SF-36 Health Survey. Qual Life Res. 2005 Jun;14(5):1433-8. doi: 10.1007/s11136-004-6014-y. PubMed 16047519 ↗
  • Andreozzi GM, Cordova RM, Scomparin A, Martini R, D'Eri A, Andreozzi F; Quality of Life Working Group on Vascular Medicine of SIAPAV. Quality of life in chronic venous insufficiency. An Italian pilot study of the Triveneto Region. Int Angiol. 2005 Sep;24(3):272-7. PubMed 16158038 ↗
  • Kim H, Hwang K, Yun SM, Kim DJ. Usage of Epinephrine Mixed With Lidocaine in Plastic Surgery. J Craniofac Surg. 2020 May/Jun;31(3):791-793. doi: 10.1097/SCS.0000000000006156. PubMed 32028367 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 18, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04758728
Lead sponsor
Junior Doctors Network-Hellas
Collaborators
General Hospital of Rhodes Andreas Papandreou, Hellenic Red Cross Hospital
Responsible party
Konstantinos Roditis (MD, MSc, Chief Resident, JDN-Hellas Board Chairperson, Junior Doctors Network-Hellas) — Principal investigator
First posted
Feb 17, 2021
Start date
Sep 10, 2015
Primary completion
May 14, 2016
Completion
Jun 10, 2016
Last update
Feb 18, 2021

Study contacts

Konstantinos Roditis, MD, MSc
principal investigator · JDN-Hellas / Department of Vascular Surgery, Hellenic Red Cross Hospital
Dimitrios Mavros, MD, MSc, PhD
study chair · Department of Vascular Surgery, Andreas Papandreou General Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion